 | • レポートコード：D0FB0638699 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：製薬・医療 |
| Single User | ￥435,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥551,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥725,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 感染性ワクチンのアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は感染性ワクチンの市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける感染性ワクチン市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・感染性ワクチンのアジア市場規模推移2014-2019 ・感染性ワクチンのアジア市場規模予測2019-2024 ・感染性ワクチンのサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（CSL Limited (Australia)、Bavarian Nordic (Denmark)、GlaxoSmithKline plc. (U.K.)、Emergent Bio Solutions Inc. (U.S.)、MedImmune LLC (U.S.)、Johnson and Johnson (U.S.)、Novartis AG (Switzerland)、Merck ） ・結論 |
Abstract:
The Asia Pacific Infectious Vaccines market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.
This report is an essential reference for who looks for detailed information on Asia Pacific Infectious Vaccines market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Infectious Vaccines market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
Key Points of this Report:
* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Infectious Vaccines
* It describes present situation, historical background and future forecast
* Comprehensive data showing Infectious Vaccines capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Infectious Vaccines manufacturers
* Infectious Vaccines market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us
The largest vendors of Asia Pacific Infectious Vaccines market: (At least 8 companies included)
* CSL Limited (Australia)
* Bavarian Nordic (Denmark)
* GlaxoSmithKline plc. (U.K.)
* Emergent Bio Solutions Inc. (U.S.)
* MedImmune LLC (U.S.)
* Johnson and Johnson (U.S.)
For complete list, please ask for sample pages.
The Infectious Vaccines market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand
The reports analysis Infectious Vaccines market in Asia Pacific by products type:
* Type I
* Type II
* Type III
The reports analysis Infectious Vaccines market in Asia Pacific by application as well:
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Table of Contents
Chapter One Infectious Vaccines Overview
1.1 Infectious Vaccines Outline
1.2 Classification and Application
1.3 Manufacturing Technology
Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis
Chapter Three Market Dynamics of Infectious Vaccines Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges
Chapter Four Asia Pacific Market of Infectious Vaccines (2014-2019)
4.1 Infectious Vaccines Supply
4.2 Infectious Vaccines Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis
Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Infectious Vaccines Supply
5.2 Infectious Vaccines Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis
Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation
Chapter Seven Asia Pacific Infectious Vaccines Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis
Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 CSL Limited (Australia)
8.2 Bavarian Nordic (Denmark)
8.3 GlaxoSmithKline plc. (U.K.)
8.4 Emergent Bio Solutions Inc. (U.S.)
8.5 MedImmune LLC (U.S.)
……
……
Chapter Nine Research Conclusions of Asia Pacific Infectious Vaccines Industry
Tables and Figures
Figure Commercial Product of Infectious Vaccines
Table Classification of Infectious Vaccines
Table Application of Infectious Vaccines
Figure Porter Five Forces Model Analysis of Asia Pacific Infectious Vaccines
Figure Production Cost Analysis of Asia Pacific Infectious Vaccines
Table Infectious Vaccines Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Infectious Vaccines Capacity List
Table 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Production List
Table 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Infectious Vaccines Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Infectious Vaccines Production Value and Growth Rate
Table 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Infectious Vaccines Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Infectious Vaccines
Table 2014-2019 Asia Pacific Import and Export of Infectious Vaccines
Table 2014-2019 Asia Pacific Infectious Vaccines Demand List by Application
Figure 2014-2019 Asia Pacific Infectious Vaccines Demand by Application
Table 2014-2019 Asia Pacific Infectious Vaccines Demand Share List by Application
Figure 2014-2019 Asia Pacific Infectious Vaccines Demand Share by Application
Table 2014-2019 Asia Pacific Infectious Vaccines Country-wise Consumption List
Figure 2014-2019 Asia Pacific Infectious Vaccines Country-wise Consumption
Table 2014-2019 Asia Pacific Infectious Vaccines Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Infectious Vaccines Country-wise Consumption Share
Table 2014-2019 Asia Pacific Infectious Vaccines Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Infectious Vaccines Capacity List
Table 2019-2024 Asia Pacific Infectious Vaccines Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Infectious Vaccines Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Infectious Vaccines Key Manufacturers Production List
Table 2019-2024 Asia Pacific Infectious Vaccines Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Infectious Vaccines Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Infectious Vaccines Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Infectious Vaccines Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Infectious Vaccines
Table 2019-2024 Asia Pacific Import and Export of Infectious Vaccines
Table 2019-2024 Asia Pacific Demand of Infectious Vaccines by Application
Figure 2019-2024 Asia Pacific Infectious Vaccines Demand by Application
Table 2019-2024 Asia Pacific Infectious Vaccines Demand Share List by Application
Figure 2019-2024 Asia Pacific Infectious Vaccines Demand Share by Application
Table 2019-2024 Asia Pacific Infectious Vaccines Country-wise Consumption List
Figure 2019-2024 Asia Pacific Infectious Vaccines Country-wise Consumption
Table 2019-2024 Asia Pacific Infectious Vaccines Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Infectious Vaccines Country-wise Consumption Share
Table 2019-2024 Asia Pacific Infectious Vaccines Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Infectious Vaccines Raw Material Suppliers
Table Key End Users List
Table Profile of CSL Limited (Australia)
Table SWOT Analysis of CSL Limited (Australia)
Table CSL Limited (Australia) Infectious Vaccines Product Specification
Table 2014-2019 CSL Limited (Australia) Infectious Vaccines Product Capacity Production Price Cost Production Value List
Figure 2014-2019 CSL Limited (Australia) Infectious Vaccines Capacity Production and Growth Rate
Figure 2014-2019 CSL Limited (Australia) Infectious Vaccines Production Global Market Share
Table SWOT Analysis of Bavarian Nordic (Denmark)
Figure Bavarian Nordic (Denmark) Infectious Vaccines Products
Table 2014-2019 Bavarian Nordic (Denmark) Infectious Vaccines Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Bavarian Nordic (Denmark) Infectious Vaccines Capacity Production and Growth Rate
Figure 2014-2019 Bavarian Nordic (Denmark) Infectious Vaccines Production Global Market Share
Table SWOT Analysis of GlaxoSmithKline plc. (U.K.)
Figure GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product
Table GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Specification
Table 2014-2019 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Capacity Production Price Cost Production Value List
Figure 2014-2019 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Capacity Production and Growth Rate
Figure 2014-2019 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Global Market Share
Table Profile of Emergent Bio Solutions Inc. (U.S.)
Table SWOT Analysis of Emergent Bio Solutions Inc. (U.S.)
Figure Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product
Table Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Specification
Table 2014-2019 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Capacity Production and Growth Rate
Figure 2014-2019 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Global Market Share
Table Profile of MedImmune LLC (U.S.)
Table SWOT Analysis of MedImmune LLC (U.S.)
Figure MedImmune LLC (U.S.) Infectious Vaccines Product
Table 2014-2019 MedImmune LLC (U.S.) Infectious Vaccines Product Capacity Production Price Cost Production Value List
Figure 2014-2019 MedImmune LLC (U.S.) Infectious Vaccines Capacity Production and Growth Rate
Figure 2014-2019 MedImmune LLC (U.S.) Infectious Vaccines Production Global Market Share
……
……
IVD感染症のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific IVD Infectious Disease market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information o…- 感染症診断のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Infectious Disease Diagnostics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed infor…
- 感染症治療のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Infectious Disease Treatment market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed informa…
- 呼吸器感染症診断のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Respiratory Infectious Disease Diagnostics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for de…
- 感染症診断検査のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Infectious Disease Diagnostics Testing market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detail…